First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects
Clinical trial NCT03309241 · COMPLETED
Trial details
- NCT number
- NCT03309241
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-17
- Primary completion
- 2018-02-21
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.